PMA and Ionomycin Induce Glioblastoma Cell Death: Activation-Induced Cell-Death-Like Phenomena Occur in Glioma Cells

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Han, Sheng ^a   Tie, Xinxin ^a   Meng, Lingxuan ^a   Wang, Yunjie ^a   Wu, Anhua ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; FAS ANTIGEN; FAS LIGAND; IONOMYCIN; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; PROPIDIUM IODIDE; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFAT1; UNCLASSIFIED DRUG;

ACTIVATION INDUCED CELL DEATH; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; ASTROCYTOMA; CANCER CELL CULTURE; CANCER INHIBITION; CELL COUNT; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; FLOW CYTOMETRY; GENE; GENE EXPRESSION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; NFAT1 GENE; NICK END LABELING; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TRANSMISSION ELECTRON MICROSCOPY; UPREGULATION; WESTERN BLOTTING;

ANTIGENS, CD95; APOPTOSIS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; FAS LIGAND PROTEIN; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; IONOMYCIN; LYMPHOCYTE ACTIVATION; NFATC TRANSCRIPTION FACTORS; T-LYMPHOCYTES; TETRADECANOYLPHORBOL ACETATE;

EID: 84885150195     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076717     Document Type: Article

References (47)

1. Pan Q, Yang XJ, Wang HM, Dong XT, Wang W, et al. (2012) Chemoresistance to temozolomide in human glioma cell line U251 is associated with increased activity of O6-methylguanine-DNA methyltransferase and can be overcome by metronomic temozolomide regimen. Cell Biochem Biophys 62: 185-191.
2. Wang Y, Li S, Chen L, You G, Bao Z, et al. (2012) Glioblastoma with an oligodendroglioma component: distinct clinical behavior, genetic alterations, and outcome. Neuro Oncol 14: 518-525.
3. Tie X, Han S, Meng L, Wang Y, Wu A, (2013) NFAT1 Is Highly Expressed in, and Regulates the Invasion of, Glioblastoma Multiforme Cells. PLoS One 8: e66008.
4. Faget DV, Lucena PI, Robbs BK, Viola JP, (2012) NFAT1 C-terminal domains are necessary but not sufficient for inducing cell death. PLoS One 7: e47868.
5. Robbs BK, Cruz AL, Werneck MB, Mognol GP, Viola JP, (2008) Dual roles for NFAT transcription factor genes as oncogenes and tumor suppressors. Mol Cell Biol 28: 7168-7181.
6. Abdul HM, Sama MA, Furman JL, Mathis DM, Beckett TL, et al. (2009) Cognitive decline in Alzheimer's disease is associated with selective changes in calcineurin/NFAT signaling. J Neurosci 29: 12957-12969.
7. Pyrzynska B, Lis A, Mosieniak G, Kaminska B, (2001) Cyclosporin A-sensitive signaling pathway involving calcineurin regulates survival of reactive astrocytes. Neurochem Int 38: 409-415.
8. Sama MA, Mathis DM, Furman JL, Abdul HM, Artiushin IA, et al. (2008) Interleukin-1beta-dependent signaling between astrocytes and neurons depends critically on astrocytic calcineurin/NFAT activity. J Biol Chem 283: 21953-21964.
9. Alvarez S, Blanco A, Fresno M, Munoz-Fernandez MA, (2011) TNF-alpha contributes to caspase-3 independent apoptosis in neuroblastoma cells: role of NFAT. PLoS One 6: e16100.
10. Gopinath S, Vanamala SK, Gujrati M, Klopfenstein JD, Dinh DH, et al. (2009) Doxorubicin-mediated apoptosis in glioma cells requires NFAT3. Cell Mol Life Sci 66: 3967-3978.
11. Ye ZJ, Yuan ML, Zhou Q, Du RH, Yang WB, et al. (2012) Differentiation and recruitment of Th9 cells stimulated by pleural mesothelial cells in human Mycobacterium tuberculosis infection. PLoS One 7: e31710.
12. Verbrugge I, Hagekyriakou J, Sharp LL, Galli M, West A, et al. (2012) Radiotherapy increases the permissiveness of established mammary tumors to rejection by immunomodulatory antibodies. Cancer Res 72: 3163-3174.
13. Stankov K, Bogdanovic G, Stankov S, Draskovic D, Grubor-Lajsic G, et al. (2012) Expression analysis of genes involved in apoptosis, proliferation and endoplasmic reticulum stress in ionomycin/PMA treated Jurkat cells. J BUON 17: 369-376.
14. Meehan AC, Mifsud NA, Nguyen TH, Levvey BJ, Snell GI, et al. (2013) Impact of commonly used transplant immunosuppressive drugs on human NK cell function is dependent upon stimulation condition. PLoS One 8: e60144.
15. Macian F, (2005) NFAT proteins: key regulators of T-cell development and function. Nat Rev Immunol 5: 472-484.
16. Catala-Rabasa A, Ndagire D, Sabio JM, Fedetz M, Matesanz F, et al. (2011) High ACSL5 transcript levels associate with systemic lupus erythematosus and apoptosis in Jurkat T lymphocytes and peripheral blood cells. PLoS One 6: e28591.
17. Yahata T, Abe N, Yahata C, Ohmi Y, Ohta A, et al. (1999) The essential role of phorbol ester-sensitive protein kinase C isoforms in activation-induced cell death of Th1 cells. Eur J Immunol 29: 727-732.
18. Ju ST, Matsui K, Ozdemirli M, (1999) Molecular and cellular mechanisms regulating T and B cell apoptosis through Fas/FasL interaction. Int Rev Immunol 18: 485-513.
19. Zhang Y, Xu G, Zhang L, Roberts AI, Shi Y, (2008) Th17 cells undergo Fas-mediated activation-induced cell death independent of IFN-gamma. J Immunol 181: 190-196.
20. Greeneltch KM, Kelly-Welch AE, Shi Y, Keegan AD, (2005) Chronic morphine treatment promotes specific Th2 cytokine production by murine T cells in vitro via a Fas/Fas ligand-dependent mechanism. J Immunol 175: 4999-5005.
21. Hamad AR, Schneck JP, (2001) Antigen-induced T cell death is regulated by CD4 expression. Int Rev Immunol 20: 535-546.
22. Wohlleben G, Ibrahim SM, Schmidt J, Toyka KV, Hartung HP, et al. (2000) Regulation of Fas and FasL expression on rat Schwann cells. Glia 30: 373-381.
23. Lee SJ, Zhou T, Choi C, Wang Z, Benveniste EN, (2000) Differential regulation and function of Fas expression on glial cells. J Immunol 164: 1277-1285.
24. Yu WR, Fehlings MG, (2011) Fas/FasL-mediated apoptosis and inflammation are key features of acute human spinal cord injury: implications for translational, clinical application. Acta Neuropathol 122: 747-761.
25. Austin JW, Fehlings MG, (2008) Molecular mechanisms of Fas-mediated cell death in oligodendrocytes. J Neurotrauma 25: 411-426.
26. Lo CA, Schiera G, Proia P, Saladino P, Savettieri G, et al. (2011) Oligodendroglioma cells shed microvesicles which contain TRAIL as well as molecular chaperones and induce cell death in astrocytes. Int J Oncol 39: 1353-1357.
27. Kwon D, Choi C, Lee J, Kim KO, Kim JD, et al. (2001) Hydrogen peroxide triggers the expression of Fas/FasL in astrocytoma cell lines and augments apoptosis. J Neuroimmunol 113: 1-9.
28. Rengarajan J, Mittelstadt PR, Mages HW, Gerth AJ, Kroczek RA, et al. (2000) Sequential involvement of NFAT and Egr transcription factors in FasL regulation. Immunity 12: 293-300.
29. Ramalho-Carvalho J, Pires M, Lisboa S, Graca I, Rocha P, et al. (2013) Altered expression of MGMT in high-grade gliomas results from the combined effect of epigenetic and genetic aberrations. PLoS One 8: e58206.
30. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, et al. (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996.
31. Zhang JX, Zhang J, Yan W, Wang YY, Han L, et al. (2013) Unique genome-wide map of TCF4 and STAT3 targets using ChIP-seq reveals their association with new molecular subtypes of glioblastoma. Neuro Oncol 15: 279-289.
32. Hughes MA, Parisi M, Grossman S, Kleinberg L, (2005) Primary brain tumors treated with steroids and radiotherapy: low CD4 counts and risk of infection. Int J Radiat Oncol Biol Phys 62: 1423-1426.
33. van der Most RG, Robinson BW, Lake RA, (2005) Combining immunotherapy with chemotherapy to treat cancer. Discov Med 5: 265-270.
34. De Palma M, Lewis CE, (2013) Macrophage regulation of tumor responses to anticancer therapies. Cancer Cell 23: 277-286.
35. Bloch O, Crane CA, Kaur R, Safaee M, Rutkowski MJ, et al. (2013) Gliomas Promote Immunosuppression through Induction of B7-H1 Expression in Tumor-Associated Macrophages. Clin Cancer Res 19: 3165-3175.
36. Roth P, Silginer M, Goodman SL, Hasenbach K, Thies S, et al. (2013) Integrin control of the transforming growth factor-beta pathway in glioblastoma. Brain 136: 564-576.
37. Ladjemi MZ, (2012) Anti-idiotypic antibodies as cancer vaccines: achievements and future improvements. Front Oncol 2: 158.
38. Mueller K, Quandt J, Marienfeld RB, Weihrich P, Fiedler K, et al. (2013) Octamer-dependent transcription in T cells is mediated by NFAT and NF-kappaB. Nucleic Acids Res 41: 2138-2154.
39. Macian F, Garcia-Rodriguez C, Rao A, (2000) Gene expression elicited by NFAT in the presence or absence of cooperative recruitment of Fos and Jun. EMBO J 19: 4783-4795.
40. Wu A, Ericson K, Chao W, Low WC, (2010) NFAT and AP1 are essential for the expression of a glioblastoma multiforme related IL-13Ra2 transcript. Cell Oncol 32: 313-329.
41. Wingett D, Long A, Kelleher D, Magnuson NS, (1996) pim-1 proto-oncogene expression in anti-CD3-mediated T cell activation is associated with protein kinase C activation and is independent of Raf-1. J Immunol 156: 549-557.
42. Van Duuren BL, Smith AC, Melchionne SM, (1978) Effect of aging in two-stage carcinogenesis on mouse skin with phorbol myristate acetate as promoting agent. Cancer Res 38: 865-866.
43. Green DR, Droin N, Pinkoski M, (2003) Activation-induced cell death in T cells. Immunol Rev 193: 70-81.
44. Robbs BK, Lucena PI, Viola JP, (2013) The transcription factor NFAT1 induces apoptosis through cooperation with Ras/Raf/MEK/ERK pathway and upregulation of TNF-alpha expression. Biochim Biophys Acta 1833: 2016-2028.
45. Pedrosa AM, Weinlich R, Mognol GP, Robbs BK, Viola JP, et al. (2010) Melatonin protects CD4+ T cells from activation-induced cell death by blocking NFAT-mediated CD95 ligand upregulation. J Immunol 184: 3487-3494.
46. Konig A, Fernandez-Zapico ME, Ellenrieder V, (2010) Primers on molecular pathways-the NFAT transcription pathway in pancreatic cancer. Pancreatology 10: 416-422.
47. Muller MR, Rao A, (2010) NFAT, immunity and cancer: a transcription factor comes of age. Nat Rev Immunol 10: 645-656.